Browsing by Author Nicolaides, C.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 16 to 30 of 30 < previous 
TitleAuthor(s)Issue date???itemlist.???
Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomasBai, M.; Vlachonikolis, J.; Agnantis, N. J.; Tsanou, E.; Dimou, S.; Nicolaides, C.; Stefanaki, S.; Pavlidis, N.; Kanavaros, P.24-Nov-2015-
Metronomic oral vinorelbine (MOVIN): a dose establishing translational and pharmacokinetic study in patients with metastatic refractory cancerBriasoulis, E.; Tolis, C.; Pappas, P.; Marselos, M.; Nicolaides, C.; Nikiforidis, L.; Nikolaidou, M.; Siarabi, O.; Tzamakou, E.; Pavlidis, N.24-Nov-2015-
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupFountzilas, G.; Stathopoulos, G.; Nicolaides, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Nikolaou, A.; Bacoyiannis, C.; Samantas, E.; Papadimitriou, C.; Kosmidis, P.; Daniilidis, J.; Pavlidis, N.24-Nov-2015-
Phase II study of 5-fluorouracil and interferon-gamma in patients with metastatic colorectal cancer. A Hellenic Cooperative Oncology Group StudyPavlidis, N.; Nicolaides, C.; Athanassiadis, A.; Beriatou, K.; Skarlos, D.; Giannakakis, T.; Kosmidis, P.; Karvounis, N.; Fountzilas, G.24-Nov-2015-
A phase II trial of carboplatin and vindesine in patients with non-small cell lung cancer. A Hellenic Cooperative Oncology Group studyPavlidis, N. A.; Klouvas, G.; Nicolaides, C.; Karantanas, A.; Beer, M.; Fountzilas, G.24-Nov-2015-
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) studyKalofonos, H. P.; Nicolaides, C.; Samantas, E.; Mylonakis, N.; Aravantinos, G.; Dimopoulos, M. A.; Gennatas, C.; Kouvatseas, G.; Giannoulis, E.; Dervenis, C.; Basdanis, G.; Pavlidis, N.; Androulakis, I.; Fountzilas, G.24-Nov-2015-
Rituximab in combination with CNOP chemotherapy in patients with previously untreated indolent non-Hodgkin's lymphomaEconomopoulos, T.; Fountzilas, G.; Pavlidis, N.; Kalantzis, D.; Papageorgiou, E.; Christodoulou, C.; Hamilos, G.; Nicolaides, C.; Dimopoulos, M.24-Nov-2015-
The role of soluble interleukin-2 (SIL-2R) receptors as a tumor marker in patients with advanced colorectal cancer (ACC)Pavlidis, N.; Bairaktari, E.; Nicolaides, C.; KalefEzra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Serum soluble interleukin-2 receptors in epithelial ovarian cancer patientsPavlidis, N. A.; Bairaktari, E.; Kalef-Ezra, J.; Nicolaides, C.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Soluble interleukin-2 receptors in patients with advanced colorectal carcinomaPavlidis, N.; Nicolaides, C.; Bairaktari, E.; Kalef-Ezra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Soluble interleukin-2 receptors in patients with advanced colorectal carcinomaPavlidis, N.; Nicolaides, C.; Bairaktari, E.; KalefEzra, J.; Athanassiadis, A.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOPEconomopoulos, T.; Dimopoulos, M. A.; Mellou, S.; Pavlidis, N.; Samantas, E.; Nicolaides, C.; Tsatalas, C.; Papadopoulos, A.; Papageogriou, E.; Papasavvas, P.; Fountzilas, G.24-Nov-2015-
Tropisetron in the prevention of acute nausea and vomiting in patients treated with high dose epirubicinNicolaides, C.; Giannakakis, T.; Skarlos, D.; Athanassiadis, A.; Fountzilas, G.; Damigos, D.; Pavlidis, N.24-Nov-2015-
The Value of Ca-125 Determination in the Serum of Patients with Non-Hodgkins-Lymphomas - a Preliminary-ReportPavlidis, N. A.; Bairaktari, E.; Kalefezra, J.; Nicolaides, C.; Briassoulis, E.; Seferiadis, C.; Fountzilas, G.24-Nov-2015-
Vinblastine and interferon-gamma combination with and without 13-cis retinoic acid for patients with advanced renal cell carcinoma. Results of two phase II clinical trialsBacoyiannis, C.; Dimopoulos, M. A.; Kalofonos, H. P.; Nicolaides, C.; Aravantinos, G.; Bafaloukos, D.; Samelis, G.; Onyenadum, A.; Kiamouris, Ch; Skarlos, D.; Pavlidis, N.; Triantafillidis, A.; Kosmidis, P.24-Nov-2015-